An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia Letter uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Piperazines
  • Proto-Oncogene Proteins
  • Pyrimidines
  • ras Proteins

publication date

  • July 18, 2008

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1038/leu.2008.124

PubMed ID

  • 18509354

Additional Document Info

start page

  • 2269

end page

  • 72

volume

  • 22

number

  • 12